Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Drug interactions may be important risk factors for methotrexate neurotoxicity, particularly in pediatric leukemia patients.
The obesity-related pathology and Th17 cells.
Whole-Genome DNA Methylation Analysis of Peripheral Blood Mononuclear Cells in Multiple Sclerosis Patients with Different Disease Courses.
Deciphering the role of DNA methylation in multiple sclerosis: emerging issues.
Novel pathologic findings in patients with Pelizaeus-Merzbacher disease.
Perturbed cholesterol homeostasis in aging spinal cord.
Working memory network dysfunction in relapse-onset multiple sclerosis phenotypes: A clinical-imaging evaluation.
Divided visual attention: A comparison of patients with multiple sclerosis and controls, assessed with an optokinetic nystagmus suppression task.
Effect of Fingolimod-Treatment on Blood Lipid Profiles of Multiple Sclerosis Patients.
Constipation prevalence in multiple sclerosis about a cohort of 81 patients.
Aquaporin-4 IgG autoimmune syndrome and immunoreactivity associated with thyroid cancer.
6-Month Effects of Fingolimod on Indexes of Cardiovascular Autonomic Control in Multiple Sclerosis.
Immunotherapy Improves Cognitive Function in Secondary Progressive Multiple Sclerosis.
Rebound Syndrome in Multiple Sclerosis After Fingolimod Cessation-Reply.
Comparative effectiveness using a matching-adjusted indirect comparison between delayed-release dimethyl fumarate and fingolimod for the treatment of multiple sclerosis.
Pregnancy Experience: Nonclinical Studies and Pregnancy Outcomes in the Daclizumab Clinical Study Program.
The effect of tacrolimus on facial nerve injury: Histopathological findings in a rabbit model.
Insights into the role of iron in immature rat model of hypoxic-ischemic brain injury.
Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis.
Peripheral and central neuronal ATF3 precedes CD4+ T-cell infiltration in EAE.
Neuroimaging findings of Zika virus infection: a review article.
Remyelination Is Correlated with Regulatory T Cell Induction Following Human Embryoid Body-Derived Neural Precursor Cell Transplantation in a Viral Model of Multiple Sclerosis.
Severe dyspnoea with alteration of the diffusion capacity of the lung associated with fingolimod treatment.
From trash to treasure: The untapped potential of endothelial microparticles in neurovascular diseases.
Mycophenolate Mofetil as a Monotherapy in Multiple Sclerosis: a multicentre retrospective study on 361 patients
Pages
« first
‹ previous
…
750
751
752
753
754
755
756
757
758
…
next ›
last »